Fredun Pharmaceuticals Ltd

Fredun Pharmaceuticals Ltd Share Price Today: Live Updates & Key Insights

Get insights on Fredun Pharmaceuticals Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.

Fredun Pharmaceuticals Ltd Share Price Chart

null at 23 Dec 2025 03:23 PM null

N/A 0.00(0.00%)

Lowest Today 0.00

Highest Today 0.00

Today's Open 0.00

Prev. Close 0.00

52 Week High 0.00

52 Week Low 0.00

Fredun Pharmaceuticals Ltd Fundamentals

Traded Volume: N/A

Market Cap(Cr): N/A

Avg Traded Price N/A

1 Year return %

Upper Circuit N/A

Lower Circuit N/A

P/E TTM 0.00

P/B Ratio 0.00

Traded Value(Cr) N/A

EPS TTM NaN

Book value/Share NaN

Dividend Yield 1Y 0.00%

Fredun Pharmaceuticals Ltd Share Price Performance

Shows the percentage change in stock price over different time periods

This section highlights Fredun Pharmaceuticals Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Fredun Pharmaceuticals Ltd share price history, short-term movements, long-term trends, and overall investor sentiment

1W N/A%

1M N/A%

3M N/A%

1Y N/A%

YTD N/A%

Fredun Pharmaceuticals Ltd Traded Volume Movement

Shows the trading volume over different time periods

This section highlights Fredun Pharmaceuticals Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment

Yesterday N/A

Day Before Yesterday N/A

1W Avg N/A

1M Avg N/A

3M Avg N/A

Fredun Pharmaceuticals Ltd Technical Details

Fredun Pharmaceuticals Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.

Support 1 N/A

Support 2 N/A

Support 3 N/A

Pivot Point : N/A

Resistance 1 N/A

Resistance 2 N/A

Resistance 3 N/A

Fredun Pharmaceuticals Ltd Corporate Actions

Fredun Pharmaceuticals Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Fredun Pharmaceuticals Ltd’s capital allocation strategies.

All

Dividends

No Dividend has been declared by null

Bonus

No Bonus has been declared by null

Splits

No Split has been declared by null

Others

Rights No Rights has been declared by null

Fredun Pharmaceuticals Ltd Peer Comparison

Shows key financial metrics for the company and its peers

This section compares Fredun Pharmaceuticals Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Fredun Pharmaceuticals Ltd's relative performance and valuation against major competitors.

Fredun Pharmaceuticals Ltd Cash Flow

Cash flow data provides a view of how money is generated and spent by Fredun Pharmaceuticals Ltd, across its operating activities, investing activities, and financing activities.

Fredun Pharmaceuticals Ltd Shareholding Pattern

This shows the ownership breakdown of Fredun Pharmaceuticals Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.

Promoter N/A%

Public N/A%

Other Institutions N/A%

FII N/A%

Mutual Funds N/A%

About Fredun Pharmaceuticals Ltd

Incorporated in 1987 as a private limited company, Fredun Pharmaceuticals Limited (FPL) was converted into a public limited company in Mar.'94. The Company was promoted by Nariman Medhora and Daulat N Medhora. The promoters initially established D N Pharma, a proprietary firm, for the manufacture and export of pharmaceutical formulations. Since 1993, D N Pharma's operations were phased out in order to switch over the business to FPL. The Company is well diversified in the business ranging from Formulations to Diagnostics to Consultancy. The Company has an unique range of products, from niche formulations , anti-diabetics to the latest antiretroviral and anti - Hypertensive products. It supplies finished formulations to over 42 Countries globally. It is associated with many Governments of different countries which have also realised the need for robust and consistent healthcare systems.The Company was set up with the objective of providing facilities for manufacturing and marketing of various pharmaceutical formulations like tablets, capsules, dry-syrups and ointments. It then set up a formulation unit at Palghar (Thane District), Maharashtra, which commenced commercial production in Aug.'94. FPL had been carrying out manufacturing operations on loan licence for reputed pharmaceutical companies like Cipla. It also manufactured for some merchant exporters, including Merind.In Apr.'96, the company came out with a public issue to register its products in the overseas market for exports; to part-finance the expansion of its business activities and to repay one of the term loans and unsecured loans to reduce the interest burden. Company is very much optimistic of revival of company's turnover by having excellent export order in hand. Company also in process of registering various drugs with different countires such as Nepal, Tanzaniya, Uganda & Sri Lanka.In 2013, Company launched 36 new products and filed 60 new products for registration. It launched a herbal dietary supplement in Africa. During 2015, three new granulation departments were introduced to the existing two departments. It launched 19 new products under the Cosmeceuticals OEM Division in 2023. It introduced 14 new products in the pet pharmaceuticals line, with another 36 in the works. It launched 16 products into the Pet Treat and Nutritional Supplement category.In FY 2024, Company launched over 110 products under the Fredun Gx brand in India, including Anti-Diabetics, Anti-Hypertensives, Anti-biotics & Anti-fungal. During FY 2025 a second Italian Tube Filling Machine and two Automatic Carton Packaging Machines have been installed. Company acquired One Pet Stop Pvt Ltd, adding grooming services and access to over 4,000 pet owners. Fredun launched Freossi Tone+ (for lactation and milk quality) and Freossi Power (for joint health and mobility), targeting livestock like cows, buffaloes, horses, and cattle in 2025.

Chairperson & Joint MD

Daulat N Medhora

Registered office 26 Manoj Industrial Premises, G D Ambedkar Marg Wadala, Mumbai, Maharashtra, 400031

FAX :91-22-40318111

Background

Incorporation Year 1987

Face Value ₹10.00

Market Lot 1

Fredun Pharmaceuticals Ltd Latest News

VIEW MORE NEWS

FAQs on Fredun Pharmaceuticals Ltd